Validation of Reduced S-gene Target Performance and Failure for Rapid Surveillance of SARS-CoV-2 Variants
Cyndi Clark, Joshua Schrecker, Matthew Hardison, View ORCID ProfileMichael S. Taitel
doi: https://doi.org/10.1101/2022.04.18.22273989
Cyndi Clark
1Aegis Sciences Corporation, Nashville, TN
PhDJoshua Schrecker
1Aegis Sciences Corporation, Nashville, TN
PharmDMatthew Hardison
1Aegis Sciences Corporation, Nashville, TN
PhDMichael S. Taitel
2Walgreens, Deerfield, IL
PhD
Data Availability
All data referred to in the manuscript are available upon reasonable request to the authors.
Posted May 06, 2022.
Validation of Reduced S-gene Target Performance and Failure for Rapid Surveillance of SARS-CoV-2 Variants
Cyndi Clark, Joshua Schrecker, Matthew Hardison, Michael S. Taitel
medRxiv 2022.04.18.22273989; doi: https://doi.org/10.1101/2022.04.18.22273989
Subject Area
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (731)
- Anesthesia (215)
- Cardiovascular Medicine (3131)
- Dermatology (266)
- Emergency Medicine (464)
- Epidemiology (13082)
- Forensic Medicine (14)
- Gastroenterology (869)
- Genetic and Genomic Medicine (4902)
- Geriatric Medicine (451)
- Health Economics (757)
- Health Informatics (3091)
- Health Policy (1109)
- Hematology (411)
- HIV/AIDS (975)
- Medical Education (457)
- Medical Ethics (121)
- Nephrology (503)
- Neurology (4671)
- Nursing (248)
- Nutrition (691)
- Oncology (2406)
- Ophthalmology (683)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (311)
- Palliative Medicine (88)
- Pathology (520)
- Pediatrics (1249)
- Primary Care Research (526)
- Public and Global Health (7233)
- Radiology and Imaging (1615)
- Respiratory Medicine (945)
- Rheumatology (463)
- Sports Medicine (403)
- Surgery (520)
- Toxicology (65)
- Transplantation (223)
- Urology (193)